Contact Getein

Pursue Excellence<br><b> Deliver Health</b>

Getein Biotech, Inc.

Pursue Excellence
Deliver Health
Taking people's wellbeing as the motivation, we are dedicated to contributing to people's health and helping people from different countries live a happy and well life.
Learn More
One Step Test for <b>SARS-CoV-2 Antigen</b>

Getein Biotech, Inc.

One Step Test for SARS-CoV-2 Antigen
Effective in Detecting Omicron, Alpha, Beta, Gamma and Delta Variants.
Learn More
Products & Solutions
Getein 10 R&D platforms, flexibly fulfill your changing needs, allowing you to work faster and more efficiently with our intelligent analytical units.
Learn More
News
Latest News
Stay tuned with us to get the latest news of Getein!
  • Exhibition | 21

    November 2022

    【CMEF 2022】Are You Ready to Meet Us?
    2022 CMEF The 86th China International Medical Equipment Fair     From November 23-26, the 86th CMEF (Shenzhen Exhibition) will hold more than 70 medical device industry themed conferences in conjunction with many industry authoritative associations, societies and enterprises, etc. Getein invites you to Shenzhen for the event!     With the theme of "New Tech Smart Future", this year's CMEF exhibition is based on innovative technology and insight into the future of the industry. Focusing on new and cutting-edge tracks that are of great concern to the society, we will jointly explore the new course, new development and new future of the industry.   Time: 2022. November 23-26 Location: Shenzhen World Exhibition & Convention Center   Booth: 13C06   In this event, Getein will bring two excellent "ACE" products, MAGICL 6000 chemiluminescence immunoassay analyzer and Metis 600 modular system, as well as a full series of products such as POCT series, diagnostic + cardiopulmonary rehabilitation comprehensive solutions, animal diagnostic series,  etc.  Welcome all experts and colleagues to visit the site!
    【CMEF 2022】Are You Ready to Meet Us?
  • Exhibition | 17

    November 2022

    【MEDICA 2022】For Every Moment, Our Passion Never Ends!
    MEDICA 2022 The great event was held successfully!     MEDICA is recognized as the world's largest hospital and medical equipment exhibition, ranking first in the world of medical trade shows with its irreplaceable scale and influence. MEDICA 2022 was held in Düsseldorf,  Germany from November 14 to 17. In this exhibition, there are more than 5,000 exhibitors worldwide, with a total exhibition area of 283, 800 square meters! As an exhibitor from China, Getein Biotech showed its advanced technology to the world, and let more and more people know the great technology of Getein Biotech.   A glance of our booth   During this exhibition, visitors and exhibitors from all over the world met with us at booth 1D64! Our attending team received a large number of visitors with their professional abilities and enthusiastic attitude!   At the exhibition, many visitors stopped by for our MAGICL 6000, this chemiluminescence immunoassay analyzer has distinct advantages like compact and space-saving, high throughput of 150T/H, and high level of automation, etc. The comprehensive introduction by the team members gave the attendees a thorough understanding of the advantages of this instrument, making a lot of people interested.     In this exhibition, the grandly "ACE" product of Getein, MAGICL 6000, was presented in the main position. This POC CLIA analyzer attracted the attention of passersby and visitors!     In addition, there were more excellent instruments on site, such as Getein 1160, Metis 600, GN 7120, etc., which we newly launched since 2021.   Long before the exhibition started, we had clients who had appointments with our team. One client from Italy said that it had been a pleasure to work with Getein and that he was very impressed with the way that we keeping pushing the envelope. As the 20 th anniversary of Getein Biotech, we are honered to have your precious trust and long-lasting support. Getein taking people's wellbeing as the motivation, we are dedicated to contributing to people's health and helping people from different countries live a happy and well life.     >>Click to review the exciting moments<<
    【MEDICA 2022】For Every Moment, Our Passion Never Ends!
  • Academic | 14

    November 2022

    World Diabetes Day——Access to Diabetes Care
    World Diabetes Day——Access to Diabetes Care   Diabetes Around the World Diabetes is a chronic, metabolic disease characterized by elevated levels of blood glucose (or blood sugar), which leads over time to serious damage to the heart, blood vessels, eyes, kidneys and nerves [1]. According to the International Diabetes Federation (IDF), there is a continued global increase in diabetes prevalence, with 537 million adults living with diabetes, and the majority living in low-and middle-income countries [2]. This number is expected to rise to 783 million by 2045, which confirms that diabetes is a significant global challenge to the health and well-being of individuals, families and societies. World Diabetes Day, established in 1991 by the International Diabetes Federation with support from WHO, falls on 14 November every year in response to growing concerns about the health and economic threat posed by diabetes.         Effective Approaches to Prevent Type 2 Diabetes There are effective approaches available to prevent type 2 diabetes and to prevent the complications and premature death that can result from all types of diabetes, including exercising regularly, eating healthily, avoiding smoking, and controlling blood pressure and lipids.       Living Well with Diabetes   Since diabetes may be diagnosed several years after onset, after complications have already arisen, an early diagnosis is important for people who are at high risk of suffering from diabetes-the longer a person lives with undiagnosed and untreated diabetes, the worse their health outcomes are likely to be. Easy access to basic diagnostics, such as blood glucose testing, should therefore be available in all health care settings. The American Diabetes Association has recommended glycated hemoglobin (HbA1c) as a possible substitute to fasting blood glucose for diagnosis of diabetes [3]. HbA1c is an important indicator of long-term glycemic control with the ability to reflect the cumulative glycemic history of the preceding two to three months. HbA1c not only provides a reliable measure of chronic hyperglycemia but also correlates well with the risk of long-term diabetes complications. Elevated HbA1c has also been regarded as an independent risk factor for coronary heart disease and stroke in subjects with or without diabetes. The valuable information provided by a single HbA1c test has rendered it as a reliable biomarker for the diagnosis and prognosis of diabetes.   References 1. World Health Organization 2. IDF Diabetes Atlas, 10th edition, International Diabetes Federation, 2021 3. The American Diabetes Association
    World Diabetes Day——Access to Diabetes Care
About Us
About Us
Getein Biotech, Inc.
20

Years of expertise

  • 1
    0 +
    Staff
  • 2
    0 + R&D Staff
  • 3
    0 Technology Platforms
  • 4
    0 Subsidiaries
  • 5
    BSI ISO 13485 & CE Certification
  • 6

    Products Sold in 110+ Countries and Territories

  • 7
    0 ㎡ Total Floor Space
  • 8
    Intelligent Manufacture
Leave your message here should you be interested by any of our product offerings, we will get back to you in minimal delay.

Home

Products

contact

service